BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8675640)

  • 1. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial structure and functional relation to abscess formation.
    Tzianabos AO; Onderdonk AB; Kasper DL
    Infect Agents Dis; 1994 Oct; 3(5):256-65. PubMed ID: 7866658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2 mediates protection against abscess formation in an experimental model of sepsis.
    Tzianabos AO; Russell PR; Onderdonk AB; Gibson FC; Cywes C; Chan M; Finberg RW; Kasper DL
    J Immunol; 1999 Jul; 163(2):893-7. PubMed ID: 10395684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.
    Tzianabos AO; Onderdonk AB; Zaleznik DF; Smith RS; Kasper DL
    Infect Immun; 1994 Nov; 62(11):4881-6. PubMed ID: 7927768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.
    Tzianabos AO; Gibson FC; Cisneros RL; Kasper DL
    J Infect Dis; 1998 Jul; 178(1):200-6. PubMed ID: 9652441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro.
    Brubaker JO; Li Q; Tzianabos AO; Kasper DL; Finberg RW
    J Immunol; 1999 Feb; 162(4):2235-42. PubMed ID: 9973499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune mechanisms in the prevention of intra-abdominal abscess formation.
    Kasper DL; Finberg RF; Crabb J; Onderdonk AB
    Scand J Infect Dis Suppl; 1989; 62():29-34. PubMed ID: 2587962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good and laudable pus.
    Gorbach SL
    J Clin Invest; 1995 Dec; 96(6):2545. PubMed ID: 8675616
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
    van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP
    J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.
    Chung DR; Kasper DL; Panzo RJ; Chitnis T; Grusby MJ; Sayegh MH; Tzianabos AO
    J Immunol; 2003 Feb; 170(4):1958-63. PubMed ID: 12574364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis.
    Gibson FC; Onderdonk AB; Kasper DL; Tzianabos AO
    J Immunol; 1998 May; 160(10):5000-6. PubMed ID: 9590249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses.
    Crabb JH; Finberg R; Onderdonk AB; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S178-84. PubMed ID: 2406870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
    Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses.
    Tzianabos AO; Kasper DL; Onderdonk AB
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S132-40. PubMed ID: 7548535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
    Kalka-Moll WM; Tzianabos AO; Wang Y; Carey VJ; Finberg RW; Onderdonk AB; Kasper DL
    J Immunol; 2000 Jan; 164(2):719-24. PubMed ID: 10623815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preexposure of the peritoneum to live bacteria increases later mixed intraabdominal abscess formation and delays mortality.
    Sawyer RG; Adams RB; Spengler MD; Pruett TL
    J Infect Dis; 1991 Mar; 163(3):664-7. PubMed ID: 1995742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.